Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US office doctors to access to Biosite's CHF (congestive heart failure) test:

This article was originally published in Clinica

Executive Summary

Henry Schein, the Melville, New York-based supplier of healthcare products, has agreed to distribute Biosite's Triage BNP test for congestive heart failure (CHF) to office-based doctors in the US. The rapid, point-of-care diagnostic device is designed to diagnose and assess the severity of CHF and to determine the level of risk of a cardiac incident among patients with acute coronary syndromes. According to the American Heart Association, around 5 million people in the US have CHF with 550,000 new cases discovered each year.

Topics

UsernamePublicRestriction

Register

MT059234

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel